A new perspective for nuclear medicine: expanding the indications for PSMA targeted imaging and therapy Frederik A. VerburgMarkus Luster Editorial Commentary 04 July 2017 Pages: 1611 - 1613
Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma-a preliminary analysis Thomas J. W. Klein NulentRobert J. J. van EsBart de Keizer Original Article Open access 07 June 2017 Pages: 1614 - 1621
Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions Stefano FantiSilvia MinozziArturo Chiti Original Article 23 May 2017 Pages: 1622 - 1635
Effects of arm truncation on the appearance of the halo artifact in 68Ga-PSMA-11 (HBED-CC) PET/MRI Ali Afshar-OromiehMaya WolfMartin T. Freitag Original Article 15 May 2017 Pages: 1636 - 1646
Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence Christian UprimnyAlexander Stephan KroissIrene Johanna Virgolini Original Article 06 June 2017 Pages: 1647 - 1655
Patterns of failure after radical prostatectomy in prostate cancer – implications for radiation therapy planning after 68Ga-PSMA-PET imaging Kilian SchillerK. SauterG. Habl Original Article 23 June 2017 Pages: 1656 - 1662
177Lu-PSMA-617 radioligand therapy and outcome in patients with metastasized castration-resistant prostate cancer Axel BräuerLena Sophie GrubertKambiz Rahbar Original Article 17 June 2017 Pages: 1663 - 1670
Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer Yong DuIgnasi CarrioVal Lewington Original Article Open access 19 June 2017 Pages: 1671 - 1678
Players of ‘hypoxia orchestra’ – what is the role of FMISO? Takuya ToyonagaKenji HirataTamaki Nagara Editorial 20 June 2017 Pages: 1679 - 1681
Monitoring early response to chemoradiotherapy with 18F-FMISO dynamic PET in head and neck cancer Milan GrkovskiNancy Y. LeeJohn L. Humm Original Article 24 May 2017 Pages: 1682 - 1691
SPECT/CT and PET/CT molecular imaging in medullary thyroid carcinoma. Are we running in the right direction? Anna Margherita MaffioneFrancesco GiammarileDomenico Rubello Editorial Commentary 22 June 2017 Pages: 1692 - 1694
68Ga-DOTATATE PET/CT in recurrent medullary thyroid carcinoma: a lesion-by-lesion comparison with 111In-octreotide SPECT/CT and conventional imaging Lilian Yuri Itaya YamagaMarcelo L. CunhaMarcelo B. G. Funari Original Article 20 April 2017 Pages: 1695 - 1701
Clinical impact of PET/CT imaging after adjuvant therapy in patients with oral cavity squamous cell carcinoma Huan-Chun LinChung-Jan KangTzu-Chen Yen Original Article 26 May 2017 Pages: 1702 - 1711
The role of 18F-FDG PET/CT in the detection of osteosarcoma recurrence Andrea AngeliniFrancesco CeciPietro Ruggieri Original Article 12 April 2017 Pages: 1712 - 1720
[18]Fluorodeoxyglucose Positron Emission Tomography for the Textural Features of Cervical Cancer Associated with Lymph Node Metastasis and Histological Type Wei-Chih ShenShang-Wen ChenChia-Hung Kao Original Article 14 April 2017 Pages: 1721 - 1731
The value of [11C]-acetate PET and [18F]-FDG PET in hepatocellular carcinoma before and after treatment with transarterial chemoembolization and bevacizumab Shuren LiMarkus Peck-RadosavljevicMarcus Hacker Original Article Open access 29 May 2017 Pages: 1732 - 1741
Imaging children suffering from lymphoma: an evaluation of different 18F-FDG PET/MRI protocols compared to whole-body DW-MRI Julian KirchnerCornelius DeuschlLale Umutlu Original Article 22 May 2017 Pages: 1742 - 1750
PET and PET/CT with radiolabeled choline in prostate cancer: a critical reappraisal of 20 years of clinical studies Giampiero GiovacchiniElisabetta GiovanniniAndrea Ciarmiello Review Article 14 April 2017 Pages: 1751 - 1776
Reply to: Predicting the outcome of peptide receptor radionuclide therapy in neuroendocrine tumors: the importance of dual-tracer imaging Giovanni PaganelliMaddalena SansoviniEmanuela Scarpi Letter to the Editor 22 March 2017 Pages: 1777 - 1778
F-18 FDG and F-18 Tau PET in posterior cortical atrophy Madhavi TripathiAbhinav BansalChandrasekhar Bal Image of the Month 06 June 2017 Pages: 1779 - 1780
Erratum to: Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients Ali Afshar-OromiehTim Holland-LetzUwe Haberkorn Erratum 28 June 2017 Pages: 1781 - 1781